NEW YORK (GenomeWeb) – Investment bank Evercore ISI has downgraded Becton Dickinson's stock to Hold from Buy based on the company's recent outperformance of the market.

Over the past two years, BD has "massively outperformed" the S&P 500 Index, wrote Evercore analyst Vijay Kumar in his note today. Evercore's elevation of Becton to a Buy in June 2013 was based on the idea that the stock was underappreciated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.